Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000668627 | SCV000793261 | likely benign | Bifunctional peroxisomal enzyme deficiency | 2017-08-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004735736 | SCV005367232 | uncertain significance | HSD17B4-related disorder | 2024-08-02 | no assertion criteria provided | clinical testing | The HSD17B4 c.187+2T>C variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant can be referred to as deep intronic variant c.113-2206T>C using transcript NM_000414. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.012% of alleles in individuals of European (Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |